- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Monday, 28 February 2011
-
Current Status:
Answered by Nicola Sturgeon on 11 March 2011
To ask the Scottish Executive what its position is on the risks of increased mupirocin consumption and resistance that might result from a Scotland-wide MRSA screening programme on admission to hospital and of staff.
Answer
Health Protection Scotland has advised that current monitoring by the Scottish MRSA Reference Laboratory indicates no significant increase in mupirocin resistance within the Pathfinder boards.
This will be continued to be monitored.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Monday, 28 February 2011
-
Current Status:
Answered by Nicola Sturgeon on 11 March 2011
To ask the Scottish Executive whether the estimates of the NHS Quality Improvement Scotland health technology assessment economic model assumptions in the report on the MRSA Screening Pathfinder Programme have been or will be subject to peer review.
Answer
Health Protection Scotland has advised that the estimates for assumptions made within the NHS QIS Health Technology Assessment (HTA) model were peer reviewed and underwent public consultation according to NHS QIS process for the production of HTAs.
Many of the estimates made in the original modelling process have in fact been confirmed by subsequent data drawn from the Pathfinder Programme and the special studies.
The information subsequently used in the MRSA Screening Pathfinder version of the model was derived from the Pathfinder Study.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Monday, 28 February 2011
-
Current Status:
Answered by Nicola Sturgeon on 11 March 2011
To ask the Scottish Executive for what reason NHS Scotland Wheelchair and Seating Services - Clinical Standards Consultation does not refer to the right to a second opinion arising from an appeal.
Answer
NHS Scotland Wheelchair and Seating Services are already fully compliant with NHS policy regarding the right to a second opinion.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Monday, 28 February 2011
-
Current Status:
Answered by Nicola Sturgeon on 11 March 2011
To ask the Scottish Executive for what reason NHS Scotland Wheelchair and Seating Services - Clinical Standards Consultation does not refer to complaints procedures.
Answer
NHS Scotland Wheelchair and Seating Services are already fully compliant with NHS complaints procedures.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Monday, 28 February 2011
-
Current Status:
Answered by Nicola Sturgeon on 11 March 2011
To ask the Scottish Executive whether the NHS Scotland Wheelchair and Seating Services - Clinical Standards Consultation will invite responses from those users, carers and voluntary sector representatives who were represented by the Wheelchair and Seating Services Project Board.
Answer
The draft clinical standards were released for a 12 week period of public consultation, which closed on 25 February 2011. All members of the Wheelchair and Seating Services Project Board were included in the distribution of consultation documents, which are also freely available on the Scottish Government website at:
http://www.scotland.gov.uk/Publications/2010/12/06095313/0.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Monday, 28 February 2011
-
Current Status:
Answered by Nicola Sturgeon on 11 March 2011
To ask the Scottish Executive what the (a) risks and (b) benefits are of rolling out a Scotland-wide MRSA screening programme for hospital admissions.
Answer
Health Protection Scotland has advised that the principal anticipated benefit of the screening programme is a reduction in MRSA infections in acute hospitals. MRSA infection has a negative impact on quality of life and length of stay in hospital, therefore lowering of colonisation rates reduces the risk of infection in the patient population.
The use of clinical risk assessment also allows pre-emptive management of patients identified as being at higher risk of MRSA colonisation in anticipation of laboratory results being available, thereby reducing the risks of transmission to other patients.
Continuing study of the epidemiology of MRSA colonisation and infection will be required.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Monday, 28 February 2011
-
Current Status:
Answered by Nicola Sturgeon on 11 March 2011
To ask the Scottish Executive what the confidence intervals are for the predicted reductions in MRSA colonisation prevalence and infection incidence associated with MRSA laboratory test-based screening.
Answer
Confidence intervals around the infection estimates are detailed for tertiary referral hospitals in the economic analyses report on page 14 in table 8-1; and for large general hospitals in the economic analyses report on page 15 in table 8-2 at:
http://www.documents.hps.scot.nhs.uk/hai/mrsa-screening/pathfinder-programme/mrsa-pathfinder-economic-2011-02-23
Health Protection Scotland (HPS) has provided the following information:
Number of Infections Five Years after Implementation of Strategy Showing Confidence Intervals for Each Estimate:
| Hospital Type | Strategy | Cases Predicted in Year Five | Confidence Interval |
| Tertiary Referral | Do Nothing | 512 | 426, 592 |
| Universal Nasal Screen | 282 | 191, 366 |
| Clinical Risk Assessment (CRA) | 322 | 235, 366 |
| CRA plus High Impact Specialties | 303 | 211, 392 |
| Large General | Do Nothing | 111 | 88,134 |
| Universal Nasal Screen | 71 | 47, 94 |
| CRA | 85 | 62, 94 |
| CRA plus High Impact Specialties | 78 | 55, 102 |
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Monday, 28 February 2011
-
Current Status:
Answered by Nicola Sturgeon on 11 March 2011
To ask the Scottish Executive what risk factors were found in those patients with MRSA infections who screened negative in the MRSA pilot screening project.
Answer
The study did not highlight these risk factors.
The single most important risk factor for infection was colonisation at the point of admission. Other risk factors included the specialty admitted to.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Monday, 28 February 2011
-
Current Status:
Answered by Nicola Sturgeon on 11 March 2011
To ask the Scottish Executive for what reason NHS Scotland Wheelchair and Seating Services - Clinical Standards Consultation does not refer to a mobility plan forming part of the agreement with the user or carer.
Answer
I refer the member to the answer to question S3W-39995 on 11 March 2011. All answers to written parliamentary questions are available on the Parliament''s website, the search facility for which can be found at:
http://www.scottish.parliament.uk/Apps2/Business/PQA/Default.aspx.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Monday, 28 February 2011
-
Current Status:
Answered by Nicola Sturgeon on 11 March 2011
To ask the Scottish Executive whether the report on the MRSA Screening Pathfinder Programme has been or will be subject to peer review.
Answer
Yes, the reports on the Pathfinder Programme were
subject to peer review by the appropriate working group; the MRSA Programme Board; and external experts.
Each report was reviewed according to HPS Quality Assurance protocol.
